Health systems with rich routine clinical data face a common governance challenge: how to make data usable for research, innovation and service improvement without weakening privacy, professional accountability or public trust. The UK Government’s £600 million (about €695 million) investment in a Health Data Research Service marks a major commitment to national health infrastructure, with the service intended to provide a single access point for health data research and approvals. A 2026 analysis published in The Lancet Digital Health places this ambition within a broad governance landscape covering data protection, confidentiality, custodianship, infrastructure and medical regulation. The service promises to accelerate innovation, improve patient outcomes and reduce costs for the National Health Service. Its success depends on more than the availability of data or technology. It will require trusted coordination across the institutions that control access, approvals, security, public confidence and the practical use of health data.
Trust as the Central Test
The UK faces pressure to restore momentum in health research. Foreign direct investment in life sciences declined by 58% between 2017 and 2023, while the UK’s phase III industry trials ranking fell from fourth to eighth. Investment in pharmaceutical research and development also declined by nearly £100 million (€116 million) in 2023. Patient recruitment to NHS clinical trials nearly halved between 2018 and 2023, with an estimated £360 million (about €417 million) in lost research funding for taxpayers.
Data-access barriers remain a primary constraint on research productivity. Access to health data can take months or years, creating friction for public studies in the public interest. The Health Data Research Service could help reverse these trends by offering an efficient and trusted route to health data. The potential benefits include support for clinical trials, global investment, artificial intelligence and patient benefit. Wider success depends on demonstrating that the UK can deliver a research service able to attract investment, enable trials, use data responsibly and ultimately benefit patients worldwide. The task is to preserve essential safeguards while eliminating friction that brings no commensurate benefit. Governance must protect privacy and maintain public trust while removing inefficient processes that add delay without clear benefit.
Fragmented Systems and Conditional Public Trust
The UK has a centralised health service and a unique patient identifier assigned at birth, yet its health data landscape remains fragmented. Data are held across NHS trusts, general practices, universities, government agencies, charities and private partners. Each operates with different approval processes and institutional cultures. Oversight also involves NHS England, the Health Research Authority, the Information Commissioner’s Office, the National Data Guardian and the Department of Health and Social Care, alongside funders, Caldicott Guardians, general practitioners, professional organisations and patient groups.
Must Read: Building Better Care Through Shared Data
Lifelong NHS records for 68 million people sit alongside longitudinal resources including UK Biobank and Genomics England. These assets offer substantial potential for discovery, but fragmented access restricts their effective use. The COVID-19 pandemic demonstrated the effect of timely and responsible data use when emergency provisions reduced normal bureaucratic barriers. RECOVERY identified life-saving treatments, OpenSAFELY supported secure analysis of millions of health records and COALESCE assessed vaccine safety across 68 million individuals. Those achievements depended on public need and pragmatic collaboration.
Public willingness to share health data remains high, but trust is conditional. Earlier national data initiatives, including care.data and the General Practice Data for Planning and Research programme, were suspended after public concern over inadequate transparency, insufficient opt-out mechanisms and possible sharing with commercial third parties without patients’ knowledge. The Health Data Research Service must earn trust through openness, accountability and participation.
A Federated Path for Data Access
A genuine single access point for health data requires coordination across more than 200 Secure Data Environments. Many operate under inconsistent governance processes that can leave users waiting months for approvals. These delays affect advances in diagnosis, treatment development and health system responsiveness. Centralised, top-down approaches have repeatedly underdelivered, so a model based on central data pooling does not match the scale and complexity of the UK landscape.
A federated approach offers a pragmatic route. Distributed Secure Data Environments can be connected through aligned governance while leaving data in place. Common standards for access, accreditation and data quality would reduce friction and support collaboration between data custodians and users. The approach also recognises the wide range of bodies involved in health data research, including regulators, data custodians, system enablers, infrastructure providers, professional bodies, industry representatives, patient organisations, charities, funders and research institutions.
The Health Data Research Service cannot function solely as an entry point for data access. Data must drive discovery, inform policy and improve care. The UK Government’s 10-year plan for the NHS will require effective health data infrastructure to improve outcomes, reduce inequalities and enhance NHS efficiency. Governance must therefore match the scale of national ambition.
The Health Data Research Service brings a major opportunity to simplify health data access while protecting privacy and public confidence. The stakeholder landscape shows why implementation will depend on governance rather than technology alone. The questions raised by the service reach beyond a single national programme: secondary use of health data will only gain lasting legitimacy where access, safeguards and public involvement develop together. The immediate priority is a service that works across existing structures without weakening safeguards. Success would strengthen health data research and deliver tangible benefits for patients and the NHS. Failure would risk another costly example of ineffective implementation and leave existing barriers in place across the system.
Source: The Lancet Digital Health
Image Credit: iStock
References:
Smith C, Boyd A, Pagel C et al. (2026) Trust, not technology: governing access to health data as the decisive challenge for the UK. The Lancet Digital Health: Online first.
